Bookkeeping Services for Biotechnology Companies in the UAE
R&D Cost Tracking, Grant Accounting, Lab Inventory & R&D Tax Credit Documentation — 2026 Guide
Quick Summary: Biotechnology companies in the UAE generate bookkeeping complexity that has little to do with transaction volume and everything to do with how R&D-heavy and multi-funded the business is — milestone-based grants, multi-currency funding tranches, lab consumables inventory, and the capitalization-versus-expensing decision on development costs all need careful, consistent treatment. Day-to-day bookkeeping also needs to generate the documentation that supports the UAE's new R&D Tax Credit, not just produce monthly management accounts. This guide breaks down exactly what bookkeeping services a biotechnology company in the UAE needs in 2026.
Biotech bookkeeping doesn't look like typical startup bookkeeping. A single month might include a milestone-based grant disbursement in one currency, lab equipment purchases that need to be assessed for capitalization, reagent and consumable inventory that expires and needs write-off tracking, and payroll for a small team of highly specialized scientific staff — all of which need to be recorded accurately and consistently, not estimated at quarter-end.
The stakes are higher than they look, too. Clean, well-documented R&D cost tracking isn't just good practice — it's the foundation for claiming the UAE's new R&D Tax Credit, for satisfying investor due diligence during fundraising, and for producing audited financials that free zone Corporate Tax status often requires regardless of company size.
This guide covers R&D cost accounting, grant and funding treatment, lab inventory, and R&D tax credit documentation for biotech companies in the UAE. Our accounting and bookkeeping services team works with R&D-heavy companies on exactly this kind of setup.
Not sure your R&D spend is being tracked in a way that supports tax credit claims?
Table of Contents
- Why Biotechnology Companies Need Specialized Bookkeeping
- Core Bookkeeping Challenges for Biotech Companies
- R&D Cost Tracking: Capitalization vs Expensing
- Grant, Milestone & Multi-Currency Funding Accounting
- Inventory for Lab Consumables & Reagents
- Supporting Documentation for the UAE R&D Tax Credit
- Payroll for Scientific & Clinical Staff
- Intercompany Cost Allocation for Multi-Entity Groups
- Choosing the Right Bookkeeping Partner
- FAQs
1. Why Biotechnology Companies Need Specialized Bookkeeping
A biotech company's cost base is dominated by R&D activity that doesn't follow a predictable monthly pattern — spend clusters around trial phases, lab equipment cycles, and milestone deliverables. Generic bookkeeping built for steady, revenue-driven businesses struggles to track this kind of lumpy, project-based spending accurately.
2. Core Bookkeeping Challenges for Biotech Companies
- Consistently distinguishing capitalizable development costs from routine R&D expense
- Recording milestone-based grant funding at the correct point, not simply when cash arrives
- Tracking lab consumables and reagent inventory, including expiry-related write-offs
- Managing payroll for scientific staff whose time may need to be allocated across specific R&D projects
- Handling intercompany cost allocation where a UAE entity sits alongside an overseas parent or research partner
3. R&D Cost Tracking: Capitalization vs Expensing
| Cost Type | Typical Treatment |
|---|---|
| Routine research activity with no assured future economic benefit | Expensed as incurred |
| Development costs meeting specific capitalization criteria (technical feasibility, intent, resources) | Capitalized and amortized over the asset's useful life |
| Lab equipment and fixed assets | Capitalized and depreciated over useful life, separate from R&D expense itself |
| Contract research organization (CRO) fees | Generally expensed, tracked against the specific project or trial phase |
4. Grant, Milestone & Multi-Currency Funding Accounting
- Recognize milestone-based grant funding as the related milestone is achieved, not simply when cash is received
- Track funding received in different currencies consistently, with a documented policy for currency translation
- Maintain clear records linking each funding tranche to the specific project or deliverable it relates to
- Reconcile grant conditions and reporting obligations against actual spend to avoid compliance gaps with funders
5. Inventory for Lab Consumables & Reagents
Lab consumables and reagents behave differently from typical business inventory — many have strict expiry dates, require controlled storage conditions, and can represent a meaningful share of operating cost for an active research program.
- Apply a consistent inventory costing method and conduct regular physical counts
- Document expiry-related write-offs with supporting evidence, since these affect both accurate margins and Corporate Tax deductions
- Track high-value or controlled reagents with tighter reconciliation than general lab supplies
6. Supporting Documentation for the UAE R&D Tax Credit
The UAE's R&D Tax Credit, effective for tax periods starting on or after 1 January 2026, offers a tiered credit of up to 50% on qualifying R&D expenditure, capped at AED 5 million per tax period, with minimum R&D staffing requirements and prior project approval from the UAE R&D Council. Bookkeeping plays a direct role in substantiating a claim.
| Documentation Needed | Why It Matters |
|---|---|
| Project-level cost tracking | Supports the link between spend and the specific approved R&D project |
| Staff time allocation records | Demonstrates the dedicated R&D headcount required to access higher credit tiers |
| Expense classification consistency | Shows qualifying R&D spend is tracked separately from general operating costs |
| Supporting invoices and contracts | Provides the audit trail needed if the claim is reviewed |
7. Payroll for Scientific & Clinical Staff
- Track time allocation for scientific staff across specific projects where relevant to R&D credit or grant reporting
- Handle specialized visa and compensation structures common for research staff recruited internationally
- Keep payroll records aligned with any staffing thresholds relevant to R&D Tax Credit tier eligibility
8. Intercompany Cost Allocation for Multi-Entity Groups
Many biotech companies operate a UAE R&D entity alongside an overseas parent, holding company, or research partner. Intercompany cost allocations — shared services, licensing, or cost-sharing arrangements — need to be priced consistently and documented to support both financial reporting accuracy and transfer pricing compliance.
9. Choosing the Right Bookkeeping Partner
A bookkeeping partner for a biotech company needs to understand R&D cost accounting and grant-based funding, not just standard startup bookkeeping. Pairing this with tax services for R&D Tax Credit support and audit and assurance for investor-ready financials keeps your records consistent as you scale. Our advisory and consultancy services team can also support broader financial strategy alongside day-to-day bookkeeping.
Get a free review of your biotech company's R&D cost tracking and documentation.
Frequently Asked Questions
How should biotech companies decide whether to capitalize or expense development costs?
Costs meeting specific criteria — such as technical feasibility and intent to complete the asset — can generally be capitalized and amortized, while routine research without assured future economic benefit is typically expensed as incurred. Consistency in applying the chosen policy matters most.
When should milestone-based grant funding be recognized as revenue or income?
Generally when the related milestone is actually achieved, rather than simply when the cash from the funder is received, to accurately reflect the company's financial position at any point in time.
What bookkeeping records support a UAE R&D Tax Credit claim?
Project-level cost tracking, staff time allocation records demonstrating dedicated R&D headcount, consistent expense classification, and supporting invoices and contracts all help substantiate a claim if it's reviewed.
How should lab consumables and reagents be tracked in a biotech company's books?
With a consistent inventory costing method, regular physical counts, and documented write-offs for expired stock, since consumables often represent a significant and variable share of operating cost.
How are intercompany costs handled between a UAE biotech entity and an overseas parent?
Shared services, licensing, or cost-sharing arrangements between related entities need to be priced consistently at arm's length and properly documented, supporting both financial reporting accuracy and transfer pricing compliance.
Ready to get your biotech company's bookkeeping R&D-credit-ready?
Talk to our accounting team today.
